Evaluation of the point-of-care devices KetoSureTM and StatStrip Express® blood ketone tests using β-hydroxybutyrate spiked samples
- 30 March 2022
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 82 (3) , 226-231
Abstract
Measurement of β-hydroxybutyrate (BHB) in blood is used clinically as a measure of ketosis when diabetic ketoacidosis is expected. With the introduction of point-of-care testing (POCT) for blood-BHB, nonproductive time is reduced to a minimum in a potential critical situation; however, studies have observed inferior quality of POCT-BHB. Recently, the POCT device KetoSure (Roche) has been introduced to the clinic. In this study, we evaluated the imprecision and linearity of KetoSure and compared this to the established StatStrip Express (Nova Biomedical) based on spiked full blood samples. We found comparable imprecision for KetoSure and StatStrip Express. However, linearity was only observed in the lower part of the measuring range for both devices. In a method comparison, higher values of BHB were measured by KetoSure than by an enzymatic endpoint spectrophotometric reference method (mean bias: 21% (95% confidence interval (CI): 4%–37%)). Conversely, StatStrip Express returned lower values of BHB (mean bias: −16% (95% CI: −38%–7%), while the widely applied POCT device FreeStyle Precision Neo (Abbott) returned values equivalent with the reference method (mean bias: 5% (95% CI: −14%–24%). In samples with concentrations of BHB above the measuring range, the POCT devices could be provoked to return falsely low results. In conclusion, the quality of KetoSure is in line with other established POCT devices; however, the KetoSure measures higher concentrations than other POCT devices. As, linearity only was observed in the lower part of the measuring range and as falsely low measures could be provoked, we advise users to interpret results with precaution.Keywords
This publication has 19 references indexed in Scilit:
- Comparative Performance Assessment of Point-of-Care Testing Devices for Measuring Glucose and Ketones at the Patient BedsideJournal of Diabetes Science and Technology, 2014
- Limitations to using point of care blood ketone testing to monitor DKA treatmentPractical Diabetes, 2013
- Blood β‐hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic reviewDiabetic Medicine, 2013
- The Role of Point-of-Care β-Hydroxybutyrate Testing in the Diagnosis of Diabetic Ketoacidosis: A ReviewHospital Practice, 2012
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusClinical Chemistry, 2011
- Joint British Diabetes Societies guideline for the management of diabetic ketoacidosisDiabetic Medicine, 2011
- Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patientsPediatric Diabetes, 2011
- Diagnostic Accuracy of Point-of-Care Testing for Diabetic Ketoacidosis at Emergency-Department TriageDiabetes Care, 2011
- Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sampleClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Urinary acetoacetate or capillary ??-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department settingEuropean Journal of Emergency Medicine, 2004